If true, and I would think it is, that Anavex only got the data from the CRO two weeks ago there a couple of questions:
1) Had the CRO not provided the Top Line Readout with the data? So just a case of putting it in Anavex format
2) How the hell did it take some 5 months for the CRO to deliver the data?
If not (1) yes the team at Anavex would have been under some pressure, perhaps also with outside help.
At times I don't know what to think when it comes to Anavex. It always sounds and feel promising, but then at closer inspection something is missing or messed up in ways I've never seen with other biotechs and so consistently.
Can't remember a trial outcome, where Anavex haven't had to subsequently clarify and defend their data the following days. But but what we said is sort of really true...kinda thing.
So very close it seems, yet no cigar.
I really can't tell where $AVXL SP goes next and for how long.
Market Data 
Markets 
AI
